Aurisco Pharmaceutical | Finanzwire

Basculer en Français

10827	Companies
234892	Keywords
163751	Articles
125725	Press releases

Headlines Articles Press releases Aurisco Pharmaceutical

Home
Companies
Aurisco Pharmaceutical

BRIEF

published on 08/12/2026 at 21:10, 2 hours ago

Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide Manufacturer

Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide TIDES Manufacturing Inclisiran Sodium
PRESS RELEASE

published on 08/12/2026 at 21:05, 2 hours 5 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Aurisco Pharmaceutical, a global Oligonucleotide and Peptide manufacturer, becomes the first generic oligonucleotide API manufacturer in the world to pass USFDA inspection. The inspection sets a new standard for safe and affordable oligonucleotides

Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide Manufacturer Inclusiran Sodium Generic TIDES

Accesswire

Published on 08/12/2026 at 23:05, 5 minutes ago

Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/12/2026 at 22:01, 1 hour 9 minutes ago

Fermi Names Lee McIntire as Chief Executive Officer
Published on 08/12/2026 at 15:42, 7 hours 28 minutes ago

Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:00, 8 hours 10 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 8 hours 25 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 21:05, 2 hours 5 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 3 hours 13 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 3 hours 33 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:50, 4 hours 20 minutes ago

Holding(s) in Company
Published on 08/12/2026 at 18:29, 4 hours 41 minutes ago

Designated Persons Notifications

Les Echos

Published on 08/10/2026 at 18:00, 2 days 5 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 5 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 2 days 11 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days 11 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 13 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE